H. Morrison

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Nguyen H. Tran, Kathryn Jones, Tao Dong, 2020, The Lancet.

Incidental findings in UK healthy volunteers screened for a COVID‐19 vaccine trial

S. Faust, A. Pollard, S. Mehdipour, 2021, Clinical and translational science.

Local Pulmonary Immunological Biomarkers in Tuberculosis

H. McShane, H. Morrison, 2021, Frontiers in Immunology.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

The Immunopathogenesis of Tuberculous Pericarditis.

R. Wilkinson, M. Ntsekhe, K. Wilkinson, 2020, Microbes and infection.

(2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99-111.

S. Madhi, K. Dheda, P. Aley, 2020 .

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

H. McShane, Susan A. Jackson, H. Morrison, 2023, Frontiers in Immunology.

Fluid on the chest

H. Morrison, J. Gilbert, W. Loughborough, 2013, Emergency Medicine Journal.